CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $120,165,474
- in 11 filings, $3.7M under 10b5-1 plans
Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-03 | Shawver Laura Director | Grant or award · Stock Option (Right to Buy) | +102,225 | 102,225 | ||
| 2024-06-03 | Rubin Jami Director | Grant or award · Stock Option (Right to Buy) | +102,225 | 102,225 | ||
| 2024-06-03 | Kathiresan Sekar Director | Grant or award · Stock Option (Right to Buy) | +102,225 | 102,225 | ||
| 2024-06-03 | INGRAM DOUGLAS S Director | Grant or award · Stock Option (Right to Buy) | +102,225 | 102,225 | ||
| 2024-06-03 | Borisy Alexis Director | Grant or award · Stock Option (Right to Buy) | +102,225 | 102,225 | ||
| 2024-06-03 | HILL LINDA A Director | Grant or award · Stock Option (Right to Buy) | +102,225 | 102,225 | ||
| 2024-06-03 | Rahmer Peter See remarks | Sale 10b5-1 | −19,864 | $6.47 | $129K | 493,470 |
| 2024-04-29 | Rahmer Peter See remarks | Sale | −1,345 | $6.38 | $9K | 513,334 |
| 2024-04-29 | Adams Brian Chief Legal Officer | Sale | −1,623 | $6.38 | $10K | 325,767 |
| 2024-04-29 | Catinazzo Thomas Chief Financial Officer | Sale | −1,695 | $6.38 | $11K | 339,803 |
| 2024-04-29 | Bergstrom Donald A President, R&D | Sale | −2,686 | $6.38 | $17K | 527,427 |
| 2024-03-27 | Catinazzo Thomas Chief Financial Officer | Sale | −348 | $7.70 | $3K | 341,498 |
| 2024-03-27 | Bergstrom Donald A President, R&D | Sale | −765 | $7.70 | $6K | 530,113 |
| 2024-03-27 | Adams Brian Chief Legal Officer | Sale | −348 | $7.70 | $3K | 327,390 |
| 2024-03-27 | Rahmer Peter See remarks | Sale | −298 | $7.70 | $2K | 514,679 |
| 2024-01-29 | Rahmer Peter See remarks | Sale | −1,651 | $9.64 | $16K | 514,977 |
| 2024-01-29 | Catinazzo Thomas Chief Financial Officer | Sale | −2,005 | $9.64 | $19K | 341,846 |
| 2024-01-29 | Bergstrom Donald A President, R&D | Sale | −3,178 | $9.64 | $31K | 530,878 |
| 2024-01-29 | Adams Brian Chief Legal Officer | Sale | −1,929 | $9.64 | $19K | 327,738 |
| 2024-01-16 | Rahmer Peter See remarks | Grant or award | +200,000 | 516,628 |
Page 10 of 17 · 329 trades